C1 esterase inhibitor (recombinant)

Known as: C1-INH, C1-INH Protein, Conestat Alfa 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1972-2017
01219722017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Methods We analyzed 137 edematous episodes requiring acute treatment and occurring in 6 C1-INH-HAE patients. The patients were… (More)
Is this relevant?
2013
2013
INTRODUCTION Administration of human C1 esterase inhibitor (Berinert(®) P) from target import is the most widespread treatment… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2012
2012
2737 inactive forms, believed to be linked to the N-terminal domain of C1INH (4). C1INH downregulated activated neutrophil and… (More)
Is this relevant?
Review
2012
Review
2012
Conestat alfa is a recombinant human C1 inhibitor used in the treatment of angioedema attacks in patients with hereditary… (More)
Is this relevant?
Review
2012
Review
2012
BACKGROUND   Hereditary angioedema (HAE) is a heterozygous deficiency of first component of complement-inhibitor (C1INH… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2012
2012
Conestat alfa is a recombinant human C1 inhibitor used in the treatment of angioedema attacks in patients with hereditary… (More)
  • figure 1
  • figure 2
Is this relevant?
Review
2009
Review
2009
OBJECTIVE To determine when newer agents, such as C1 esterase inhibitor protein (C1-INH), should be considered as prophylaxis to… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1987
1987
In bacteremic pigs, both administered human C1INH and endogenous C1INH lost inhibitory activity. In septic pigs which received… (More)
Is this relevant?
1976
1976
Kinin-forming and esterolytic activity in human citrate plasma has been activated by treatment of the plasma with acetone. By far… (More)
  • figure 1
  • figure 2
  • figure 5
  • figure 4
  • figure 6
Is this relevant?
1972
1972
The conversion of the plasminogen proactivator to plasminogen activator by activated Hageman factor or its fragments has been… (More)
  • figure 3
  • figure 6
  • figure 7
  • figure 8
  • figure 11
Is this relevant?